These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


504 related items for PubMed ID: 2405804

  • 21. [Simvastatin in the treatment of familial hypercholesterolemia].
    Ceska R, Sobra J, Procházková R, Kvasilová M.
    Cas Lek Cesk; 1995 May 17; 134(10):310-3. PubMed ID: 7788650
    [Abstract] [Full Text] [Related]

  • 22. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
    Mölgaard J, von Schenck H, Olsson AG.
    Eur J Clin Pharmacol; 1989 May 17; 36(5):455-60. PubMed ID: 2502417
    [Abstract] [Full Text] [Related]

  • 23. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
    Darioli R, Bovet P, Brunner HR, Bercher L.
    Schweiz Med Wochenschr; 1990 Jan 27; 120(4):85-91. PubMed ID: 2305221
    [Abstract] [Full Text] [Related]

  • 24. Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia.
    Deslypere JP.
    Acta Cardiol; 1989 Jan 27; 44(5):379-88. PubMed ID: 2690545
    [Abstract] [Full Text] [Related]

  • 25. [Familial hypercholesterolemia--intensive diet therapy combined with drug therapy].
    Stugaard M, Wiig I, Lund H, Ose L, Norseth J.
    Tidsskr Nor Laegeforen; 1992 Aug 30; 112(20):2642-6. PubMed ID: 1412289
    [Abstract] [Full Text] [Related]

  • 26. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
    Darling GM, Johns JA, McCloud PI, Davis SR.
    N Engl J Med; 1997 Aug 28; 337(9):595-601. PubMed ID: 9271481
    [Abstract] [Full Text] [Related]

  • 27. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF, Keller U, Del Bufalo A, Reutter FW, Baur HR, Golay A, Bertel O, Kummer H, Kistler H, Ammann F.
    Schweiz Med Wochenschr; 1989 Dec 02; 119(48):1719-23. PubMed ID: 2694363
    [Abstract] [Full Text] [Related]

  • 28. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 29. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov 25; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 30. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS, Illingworth DR.
    J Lab Clin Med; 1989 Nov 25; 114(5):554-62. PubMed ID: 2809398
    [Abstract] [Full Text] [Related]

  • 31. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up.
    Behrens-Baumann W, Thiery J, Wieland E, Fieseler HG, Seidel D.
    Arzneimittelforschung; 1992 Aug 25; 42(8):1023-4. PubMed ID: 1418074
    [Abstract] [Full Text] [Related]

  • 32. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov 25; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 33. Clinical experience with simvastatin compared with cholestyramine.
    Erkelens DW, Baggen MG, Van Doormaal JJ, Kettner M, Koningsberger JC, Mol MJ.
    Drugs; 1988 Nov 25; 36 Suppl 3():87-92. PubMed ID: 3254824
    [Abstract] [Full Text] [Related]

  • 34. Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia.
    Ytre-Arne K, Nordøy A.
    J Intern Med; 1989 Nov 25; 226(5):285-90. PubMed ID: 2681508
    [Abstract] [Full Text] [Related]

  • 35. Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants.
    Farmer JA, Washington LC, Jones PH, Shapiro DR, Gotto AM, Mantell G.
    Clin Ther; 1992 Nov 25; 14(5):708-17. PubMed ID: 1468089
    [Abstract] [Full Text] [Related]

  • 36. [Effects of simvastatin on atherogenic blood lipid pattern].
    Alessandri C, Peverini F, Basili S, Barsi R, Paradiso M, Marotta P, Censi C, Cordova C, Balsano F.
    Recenti Prog Med; 1991 Apr 25; 82(4):225-9. PubMed ID: 1857842
    [Abstract] [Full Text] [Related]

  • 37. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.
    Clin Ther; 2005 Jul 25; 27(7):1074-82. PubMed ID: 16154486
    [Abstract] [Full Text] [Related]

  • 38. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM, Thompson GR.
    Q J Med; 1990 Feb 25; 74(274):165-75. PubMed ID: 2111917
    [Abstract] [Full Text] [Related]

  • 39. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Feb 25; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 40. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G, Rusconi C, Faggiano P, Sabatini T, Oneglia C, Gardini A.
    Minerva Cardioangiol; 1993 Mar 25; 41(3):105-9. PubMed ID: 8510811
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.